Marina Biotech, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1953
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Marina Biotech, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Marina Biotech, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Marina Biotech, Inc. (Marina Biotech or ‘the company’) is a biotechnology company focused on the development and commercialization of nucleic acid-based therapies to treat orphan diseases. The company provides drugs to treat hypertension, arthritis, pain and others. The company offers Prestalia, a single-pill fixed dose combination and amlodipine besylate, a calcium channel blocker for the treatment of hypertension. Its clinical development programs include IT-102 and IT-103, a celecoxib program drug for the treatment of combined arthritis pain/hypertension and the treatment of pain requiring a high dose of celecoxib; CEQ508, an oral delivery of small interfering RNA against beta-catenin, combined with IT-102 to for familial adenomatous polyposis; and CEQ508 combined with IT-103 to treat colorectal cancer. The company is into research and development of pipeline products. Marina Biotech is headquartered in City of Industry, California, the US.

Scope

- Detailed information on Marina Biotech, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Marina Biotech, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Marina Biotech, Inc. including a breakdown and examination of key business segments
- Intelligence on Marina Biotech, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Marina Biotech, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Marina Biotech, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Marina Biotech, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Marina Biotech, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Marina Biotech, Inc.: Company Overview 9
Marina Biotech, Inc.: Overview and Key Facts 9
Marina Biotech, Inc.: Overview 9
Marina Biotech, Inc.: Key Facts 9
Marina Biotech, Inc.: Key Employees 11
Marina Biotech, Inc.: Key Employee Biographies 12
Marina Biotech, Inc.: Major Products and Services 14
Marina Biotech, Inc.: Company History 15
Marina Biotech, Inc.: Management Statement 19
Marina Biotech, Inc.: Locations and Subsidiaries 21
Marina Biotech, Inc.: Key Competitors 22
Marina Biotech, Inc.: Company Analysis 23
Marina Biotech, Inc.: Business Description 23
Marina Biotech, Inc.: SWOT Analysis 24
Marina Biotech, Inc.: SWOT Overview 24
Marina Biotech, Inc.: Strengths 24
Marina Biotech, Inc.: Weaknesses 25
Marina Biotech, Inc.: Opportunities 25
Marina Biotech, Inc.: Threats 26
Marina Biotech, Inc.: Corporate Financial Deals Activity 27
Marina Biotech, Inc.: Financial Deals Overview 27
Marina Biotech, Inc.: Targets and Partners 29
Marina Biotech, Inc.: Top Deals 2014 – 2018YTD* 30
Marina Biotech, Inc.: Mergers and Acquisitions 31
Marina Biotech, Inc.: Capital Raising 32
Marina Biotech, Inc.: Partnership 33
Marina Biotech, Inc.: Divestments 34
Marina Biotech, Inc.: Recent Developments 35
Marina Biotech, Inc.: News and Events Summary 35
Marina Biotech, Inc.: Contracts 38
Marina Biotech, Inc.: Corporate Governance 38
Marina Biotech, Inc.: Financial Performance 40
Marina Biotech, Inc.: Market Developments 40
Marina Biotech, Inc.: Research & Development 41
Appendix 43
Contact Us 43
Methodology 43
About MarketLine 44

List of Tables
Table 1: Marina Biotech, Inc.: Key Facts
Table 2: Marina Biotech, Inc.: Key Employees
Table 3: Marina Biotech, Inc.: Locations and Subsidiaries
Table 4: Marina Biotech, Inc.: Key Competitors
Table 5: Marina Biotech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Marina Biotech, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Marina Biotech, Inc.: Targets and Partners
Table 8: Marina Biotech, Inc.: Top Deals 2014 - 2018YTD*
Table 9: Marina Biotech, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Marina Biotech, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: Marina Biotech, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: Marina Biotech, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Marina Biotech, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: Marina Biotech, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Marina Biotech, Inc.: News and Events Summary
Table 16: Marina Biotech, Inc.: Contracts
Table 17: Marina Biotech, Inc.: Corporate Governance
Table 18: Marina Biotech, Inc.: Financial Performance
Table 19: Marina Biotech, Inc.: Market Developments
Table 20: Marina Biotech, Inc.: Research & Development

List of Figures
Figure 1: Marina Biotech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Marina Biotech, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Marina Biotech, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Marina Biotech, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 5: Marina Biotech, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 6: Marina Biotech, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Marina Biotech, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: Marina Biotech, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Marina Biotech, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atria Plc:戦略・SWOT・企業財務分析
    Atria Plc - Strategy, SWOT and Corporate Finance Report Summary Atria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Azarga Metals Corp (AZR):企業の財務・戦略的SWOT分析
    Azarga Metals Corp (AZR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Montisera Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Montisera Ltd (Montisera) focuses on discovering, developing and commercialising bioactive compounds and molecules for pharmaceutical and food industries. Its pipeline portfolio includes Montisera D15 1 for alcoholism; Montisera D 4 for treating lower urinary tract symptoms, Montisera D15 2 …
  • GIZEH Raucherbedarf GmbH:企業の戦略的SWOT分析
    GIZEH Raucherbedarf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • CTS Corp (CTS):企業の財務・戦略的SWOT分析
    Summary CTS Corp (CTS) is a manufacturer of actuators, sensors and electronic components. The company offers products such as controls, pedals, piezoelectric sense products, sensors, switches, transducers, RFI filters, frequency control products, RF filters, specialty capacitors, specialty resistors …
  • China Medical System Holdings Ltd (867):企業の財務・戦略的SWOT分析
    Summary China Medical System Holdings Ltd (CMS) is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. The company offers products such as deanxit, ursofalk, augentropfen stulln mono eye-drops, exacin, xinhuosu, salofalk …
  • Toshiba America Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • Super Dragon Technology Co., Ltd. (9955):企業の財務・戦略的SWOT分析
    Super Dragon Technology Co., Ltd. (9955) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Zweites Deutsches Fernsehen:企業の戦略的SWOT分析
    Zweites Deutsches Fernsehen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Arkema SA:企業の戦略・SWOT・財務情報
    Arkema SA - Strategy, SWOT and Corporate Finance Report Summary Arkema SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • BrainStorm Cell Therapeutics Inc (BCLI):企業の財務・戦略的SWOT分析
    Summary BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy pl …
  • Avalara Inc:企業のM&A・事業提携・投資動向
    Avalara Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Avalara Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Fluxys SA:企業の戦略的SWOT分析
    Fluxys SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Mainstream Renewable Power Ltd:電力:M&Aディール及び事業提携情報
    Summary Mainstream Renewable Power Ltd (Mainstream) is the renewable energy developer. The company is involved in developing, financing, constructing, and operating large-scale renewable energy plants. It also develops and builds onshore and offshore wind and solar power plants. The company sells th …
  • Dalet S.A. (DLT):企業の財務・戦略的SWOT分析
    Dalet S.A. (DLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ramco-Gershenson Properties Trust:企業のM&A・事業提携・投資動向
    Ramco-Gershenson Properties Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ramco-Gershenson Properties Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Tessa Therapeutics Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that develops and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response to identify and exterminate cancer cells. The company provides products for various c …
  • Alitair Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alitair Pharmaceuticals Inc (Alitair) is a pharmaceutical company that provides orphan drugs and medicine products. The company provides orphan drug products and RX and OTC cough and cold products. It offers orphan drug products such as ALT and oral drugs that are widely used to treat variou …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrol …
  • PT Garuda Indonesia (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT Garuda Indonesia (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Garuda Indonesia (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆